---
document_datetime: 2023-09-21 17:47:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/multaq-epar-all-authorised-presentations_en.pdf
document_name: multaq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.871808
conversion_datetime: 2025-12-19 06:06:35.732122
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging         | Package size    |
|-----------------|-----------------|------------|-----------------------|---------------------------|-------------------|-----------------|
| EU/1/09/591/001 | Multaq          | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 20 tablets      |
| EU/1/09/591/002 | Multaq          | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 50 tablets      |
| EU/1/09/591/003 | Multaq          | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 60 tablets      |
| EU/1/09/591/004 | Multaq          | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 100 x 1 tablets |